Previous Article | Next Article ![]()
Journal of Clinical Microbiology, October 2000, p. 3670-3674, Vol. 38, No. 10
Section of Infectious
Diseases1 and Microbiology Research
Laboratory,2 Gundersen Lutheran Medical
Center, La Crosse, Wisconsin 54601; Wisconsin State
Laboratory of Hygiene,3 and Department
of Medical Microbiology and Immunology, University of
Wisconsin,4 Madison, Wisconsin 53706; and
Solvay Animal Health, Inc., Mendota Heights, Minnesota
551205
Received 5 May 2000/Returned for modification 25 June 2000/Accepted 28 July 2000
Detection of borreliacidal antibodies is an accurate serodiagnostic
test for confirmation of Lyme disease in humans. In this study, 13 pathogen-free beagles, 12 to 26 weeks old, were infected with
Borrelia burgdorferi by tick challenge. Dogs were monitored for clinical signs and symptoms of Lyme disease along with
borreliacidal antibody production against B. burgdorferi
sensu stricto isolates 297 and 50772. Ten (77%) dogs developed
lameness in one or more legs within 210 days after attachment of
Ixodes scapularis ticks. Eight (80%) of the lame animals
had concurrent fever of
0095-1137/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
Detection of Borreliacidal Antibodies in Dogs after Challenge
with Borrelia burgdorferi-Infected Ixodes
scapularis Ticks
38°C. Spirochetes were also recovered from
the skin and joints of 12 (92%) dogs, but rarely from other organs.
Borreliacidal antibodies against B. burgdorferi isolate 297 were detected in only four (31%) dogs, and the levels of killing
antibodies remained low for the duration of the infection. In contrast,
borreliacidal antibodies against B. burgdorferi isolate
50772 were detected in 13 (100%) dogs within 21 days of infection.
Furthermore, the borreliacidal antibody levels correlated with the
severity of B. burgdorferi infection. Detection of
borreliacidal antibodies, especially against B. burgdorferi
isolate 50772, is also a reliable serodiagnostic test for detection of
Lyme disease in dogs.
*
Corresponding author. Mailing address: Microbiology
Research Laboratory, Gundersen Lutheran Medical Center, 1836 South
Ave., La Crosse, WI 54601. Phone: (608) 782-7300, ext. 2042. Fax: (608) 791-6602. E-mail: scallist{at}gundluth.org.
Present address: DiaSorin, Inc., Stillwater, MN 55082.
This article has been cited by other articles:
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»